IDEAS home Printed from
   My bibliography  Save this paper

The influence of local institutional and historical frameworks on a globalized industry: The case of the pharmaceutical industry in France and Quebec


  • Maé Geymond

    () (CES - Centre d'économie de la Sorbonne - UP1 - Université Panthéon-Sorbonne - CNRS - Centre National de la Recherche Scientifique, UP1 - Université Panthéon-Sorbonne)


In this paper, we combine the Varieties of Capitalism and the global value chain approaches, considering the interaction between lead firms' global strategies and national capitalism, to show how local pharmaceutical employment results from this interaction. Our analysis is grounded in the comparison between France and Quebec. The first part presents the relevant differences in both historical and institutional elements. Second, after highlighting the similarities that can be attributed to global dynamics, we detail the mechanisms by which local institutions shape the global value chain implantation, giving different forms to the employment structure and dynamics. We show that France is clearly oriented towards manufacturing activity because of industrial history and market features, whereas Quebec has a commercial specialty and an outsourced R&D as a result of high prices and the global organization of research.

Suggested Citation

  • Maé Geymond, 2020. "The influence of local institutional and historical frameworks on a globalized industry: The case of the pharmaceutical industry in France and Quebec," Post-Print halshs-02900915, HAL.
  • Handle: RePEc:hal:journl:halshs-02900915
    Note: View the original document on HAL open archive server:

    Download full text from publisher

    File URL:
    Download Restriction: no

    References listed on IDEAS

    1. Philippe Abecassis & Nathalie Coutinet, 2017. "Les politiques du médicament dans un contexte d’austérité en France et au Royaume-Uni : quel impact sur le modèle de production des big pharma ?," CEPN Working Papers 2017-01, Centre d'Economie de l'Université de Paris Nord.
    2. Cristina Fróes de Borja Reis & André Barroso de Souza, 2018. "Drawing value curves: lessons from financial statements of the world’s biggest manufacturing corporations," Revue d'économie industrielle, De Boeck Université, vol. 0(3), pages 229-262.
    3. Cédric Durand & David Flacher & Vincent Frigant, 2018. "Étudier les chaînes globales de valeur comme une forme d’organisation industrielle," Revue d'économie industrielle, De Boeck Université, vol. 0(3), pages 13-34.
    4. Coralie Perez & Nadine Thèvenot & Nathalie Berta & Delphine Brochard & Noélie Delahaie & Sophie Jallais & Corinne Perraudin & Catherine Sauviat & Julie Valentin, 2015. "Modes d’ajustement par le travail en temps de crise : des relations professionnelles sous tension," Post-Print hal-01306493, HAL.
    5. Geoffroy Labrouche & Med Kechidi, 2016. "La stratégie d'innovation ouverte de Sanofi," Post-Print hal-01346730, HAL.
    6. Matthieu Montalban, 2011. "La financiarisation des Big Pharma : de l'insoutenable modèle blockbuster à son dépassement ?," Post-Print hal-00651718, HAL.
    7. Bruno Amable, 2005. "Les cinq capitalismes. Diversité des systèmes économiques et sociaux dans la mondialisation," Post-Print halshs-00310487, HAL.
    8. Bruno Amable, 2005. "Les cinq capitalismes. Diversité des systèmes économiques et sociaux dans la mondialisation," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) halshs-00310487, HAL.
    9. Patricia M. Danzon & Andrew Epstein & Sean Nicholson, 2007. "Mergers and acquisitions in the pharmaceutical and biotech industries," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 307-328.
    10. Enda Hannon, 2016. "Industrial policy and employment in the UK: evidence from the pharmaceutical sector," Industrial Relations Journal, Wiley Blackwell, vol. 47(1), pages 2-20, January.
    11. Patrick Pauriche & Frédéric Rupprecht, 1998. "Le secteur pharmaceutique, un secteur aux multiples enjeux," Économie et Statistique, Programme National Persée, vol. 312(1), pages 7-20.
    12. Lexchin, Joel, 1997. "After compulsory licensing: coming issues in Canadian pharmaceutical policy and politics," Health Policy, Elsevier, vol. 40(1), pages 69-80, April.
    Full references (including those not matched with items on IDEAS)

    More about this item


    political economy; varieties of capitalism; industrial organization; local government; multinational firms; économie politique; variété des capitalismes; organisation industrielle; gouvernement local; firmes multinationales;

    NEP fields

    This paper has been announced in the following NEP Reports:


    Access and download statistics


    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hal:journl:halshs-02900915. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (CCSD). General contact details of provider: .

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.